Prostate Cancer Clinical Trial
Robot-assisted laparoscopic prostatectomy (RALP) is widely performed due to its many
advantages, including a reduced need for blood transfusion and fewer surgical complications
compared with conventional open prostatectomy. As this approach is also recommended in
elderly patients with serious comorbidities, optimal fluid therapy guidance during this
procedure is important.
Dynamic variables such as pulse pressure variation (PPV) and stroke volume variation (SVV)
are used to predict and guide fluid therapy during controlled ventilation. These variables
arise from heart-lung interactions during positive pressure ventilation, which influence
left ventricular stroke volume (SV). RALP requires carbon dioxide insufflation and the steep
Trendelenburg position to optimise surgical conditions, and can reduce cardiac output and
respiratory compliance. Accordingly, the usefulness of PPV and SVV, which are affected by
changes in intrathoracic pressure, in predicting fluid responsiveness during laparoscopic
surgery under these conditions may be questioned. A recent study established that PPV and
SVV derived by uncalibrated pulse contour analysis had a relatively poor capacity to predict
fluid responsiveness during laparoscopy on dynamic preload indices. In contrast, another
study SVV measured by oesophageal Doppler monitor (ODM) could predict fluid responsiveness
during laparoscopic surgery.
The CardioQ-ODM+ combines the proven ODM Doppler measurement of blood flow with pulse
contour analysis, which is quickly and easily calibrated from the Doppler signal. We
hypothesized that PPV and SVV measured by calibrated pulse contour analysis would be a good
indicator of fluid responsiveness during laparoscopy with pneumoperitoneum.
The primary objective of this study was to demonstrate that PPV and SVV measured by
calibrated pulse contour analysis of CardioQ-ODM+ can accurately predict fluid
responsiveness during RALP, which involves both pneumoperitoneum and the Trendelenburg
position. Investigators also assessed the capacity of other dynamic variables (SPV [systolic
pressure variation], and SVV determined by ODM Doppler flow, dynamic elastance [PPV/SVV] and
corrected flow time [FTc]) to predict fluid responsiveness during RALP.
n/a
Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Screening
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05540392 -
An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues
|
Phase 1/Phase 2 | |
Recruiting |
NCT05613023 -
A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT
|
Phase 3 | |
Recruiting |
NCT05156424 -
A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT03177759 -
Living With Prostate Cancer (LPC)
|
||
Completed |
NCT01331083 -
A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer
|
Phase 2 | |
Recruiting |
NCT05540782 -
A Study of Cognitive Health in Survivors of Prostate Cancer
|
||
Active, not recruiting |
NCT04742361 -
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer
|
Phase 3 | |
Completed |
NCT04400656 -
PROState Pathway Embedded Comparative Trial
|
||
Completed |
NCT02282644 -
Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry
|
N/A | |
Recruiting |
NCT06305832 -
Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
|
Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05761093 -
Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
|
||
Completed |
NCT04838626 -
Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection
|
Phase 2/Phase 3 | |
Recruiting |
NCT03101176 -
Multiparametric Ultrasound Imaging in Prostate Cancer
|
N/A | |
Completed |
NCT03290417 -
Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer
|
N/A | |
Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
Completed |
NCT01497925 -
Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer
|
Phase 1 | |
Recruiting |
NCT03679819 -
Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
|
||
Completed |
NCT03554317 -
COMbination of Bipolar Androgen Therapy and Nivolumab
|
Phase 2 | |
Completed |
NCT03271502 -
Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy
|
N/A |